191 related articles for article (PubMed ID: 15914734)
1. FDA warns antipsychotic drugs may be risky for elderly.
Kuehn BM
JAMA; 2005 May; 293(20):2462. PubMed ID: 15914734
[No Abstract] [Full Text] [Related]
2. Optimizing atypical antipsychotic treatment strategies in the elderly.
Katz IR
J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
[No Abstract] [Full Text] [Related]
3. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
Wang PS; Schneeweiss S; Setoguchi S; Patrick A; Avorn J; Mogun H; Choudhry NK; Brookhart MA
J Clin Psychopharmacol; 2007 Dec; 27(6):707-10. PubMed ID: 18004143
[No Abstract] [Full Text] [Related]
4. Metabolic effects of the atypical antipsychotics.
Wooten J
South Med J; 2007 Aug; 100(8):771-2. PubMed ID: 17713300
[No Abstract] [Full Text] [Related]
5. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics for the treatment of disruptive behavior.
Lohr WD; Honaker J
Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
[No Abstract] [Full Text] [Related]
7. The value of atypical antipsychotics in the treatment of schizophrenia.
Jessen LM
Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
[No Abstract] [Full Text] [Related]
8. FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
Kuehn BM
JAMA; 2009 Aug; 302(8):833-4. PubMed ID: 19706851
[No Abstract] [Full Text] [Related]
9. Switching antipsychotic medications: not enough, too often, or just right?
Weiden PJ
Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
[No Abstract] [Full Text] [Related]
10. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
McDougle CJ; Stigler KA; Erickson CA; Posey DJ
J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
[TBL] [Abstract][Full Text] [Related]
11. Neutropenia associated with quetiapine, olanzapine, and aripiprazole.
Lander M; Bastiampillai T
Aust N Z J Psychiatry; 2011 Jan; 45(1):89. PubMed ID: 21058927
[No Abstract] [Full Text] [Related]
12. Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.
Cohen D; Correll CU
J Clin Psychiatry; 2009 May; 70(5):765-6. PubMed ID: 19552870
[No Abstract] [Full Text] [Related]
13. The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Citrome L; Volavka J
Postgrad Med; 2004 Oct; 116(4):49-51, 55-9, 63. PubMed ID: 15510593
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Pathak P; West D; Martin BC; Helm ME; Henderson C
Psychiatr Serv; 2010 Feb; 61(2):123-9. PubMed ID: 20123816
[TBL] [Abstract][Full Text] [Related]
15. Second-generation antipsychotics cause weight gain in youths.
Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
[No Abstract] [Full Text] [Related]
16. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Dubois D
Curr Opin Pediatr; 2005 Apr; 17(2):227-33. PubMed ID: 15800418
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive antipsychotics for major depression.
Med Lett Drugs Ther; 2011 Sep; 53(1373):74-5. PubMed ID: 21921872
[No Abstract] [Full Text] [Related]
19. Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
Turner EH; Knoepflmacher D; Shapley L
PLoS Med; 2012; 9(3):e1001189. PubMed ID: 22448149
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]